CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


23-December-2014
Cerilliant now offers a stable-labeled internal standard of the nonbenzodiazepine metabolite, Zopiclone-N-Oxide-D4.

Zopiclone-N-Oxide-D4, Z-014
100 µg/mL in Methanol with 1% 1 M HCl

A stable-labeled internal standard suitable for quantitation of zopiclone N-oxide levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, or forensic analysis. Zopiclone N-oxide is a primary, active metabolite of zopiclone in urine as well as a major pharmaceutical impurity of zopiclone known as Eszopiclone Impurity A. The parent drug, zopiclone, is a non-benzodiazepine hypnotic sold under the trade names Imovane® and Zimovane® and is used in the treatment of insomnia.

Coming soon - Cerilliant will introduce Certified Spiking Solutions® of  N-Desmethylzopiclone (D-111) and N-Desmethylzopiclone-D4 (D-112).                


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn